Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rodrigo F. Chuaqui is active.

Publication


Featured researches published by Rodrigo F. Chuaqui.


Science | 1996

Laser Capture Microdissection

Michael R. Emmert-Buck; Robert F. Bonner; Paul D. Smith; Rodrigo F. Chuaqui; Zhengping Zhuang; Seth R. Goldstein; Rhonda A. Weiss; Lance A. Liotta

Laser capture microdissection (LCM) under direct microscopic visualization permits rapid one-step procurement of selected human cell populations from a section of complex, heterogeneous tissue. In this technique, a transparent thermoplastic film (ethylene vinyl acetate polymer) is applied to the surface of the tissue section on a standard glass histopathology slide; a carbon dioxide laser pulse then specifically activates the film above the cells of interest. Strong focal adhesion allows selective procurement of the targeted cells. Multiple examples of LCM transfer and tissue analysis, including polymerase chain reaction amplification of DNA and RNA, and enzyme recovery from transferred tissue are demonstrated.


Cancer | 1997

General mechanisms of metastasis

Elisa C. Woodhouse; Rodrigo F. Chuaqui; Lance A. Liotta

In the present article, the steps involved in the process of tumor metastasis are discussed. Several events are required for malignant cells to leave the primary tumor and proliferate at a distant site: vessel formation (angiogenesis), cell attachment, invasion (matrix degradation, cell motility), and cell proliferation. Molecular mechanisms underlying each of these steps are described. Based on blocking these processes, new anti‐metastasis therapies are being developed. Cancer 1997; 80:1529‐37.


Nature Genetics | 2002

Post-analysis follow-up and validation of microarray experiments

Rodrigo F. Chuaqui; Robert F. Bonner; Carolyn J.M. Best; John W. Gillespie; Michael J. Flaig; Stephen M. Hewitt; John Phillips; David B. Krizman; Michael A. Tangrea; Mamoun Ahram; W. Marston Linehan; Vladimir Knezevic; Michael R. Emmert-Buck

Measurement of gene-expression profiles using microarray technology is becoming increasingly popular among the biomedical research community. Although there has been great progress in this field, investigators are still confronted with a difficult question after completing their experiments: how to validate the large data sets that are generated? This review summarizes current approaches to verifying global expression results, discusses the caveats that must be considered, and describes some methods that are being developed to address outstanding problems.


American Journal of Pathology | 1999

Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis

Falko Fend; Michael R. Emmert-Buck; Rodrigo F. Chuaqui; Kristina A. Cole; Jeffrey Lee; Lance A. Liotta; Mark Raffeld

Microdissection of routinely stained or unstained frozen sections has been used successfully to obtain purified cell populations for the analysis of cell-specific gene expression patterns in primary tissues with a complex mixture of cell types. However, the precision and usefulness of microdissection is frequently limited by the difficulty to identify different cell types and structures by morphology alone. We therefore developed a rapid immunostaining procedure for frozen sections followed by laser capture microdissection (LCM) and RNA extraction, which allows targeted mRNA analysis of immunophenotypically defined cell populations. After fixation, frozen sections are immunostained under RNAse-free conditions using a rapid three-step streptavidin-biotin technique, dehydrated and immediately subjected to LCM. RNA is extracted from captured tissue, DNAse I treated, and reverse transcribed. Acetone-, methanol-, or ethanol/acetone-fixed sections give excellent immunostaining after 12 to 25 minutes total processing time. Specificity, precision, and speed of microdissection is markedly increased due to improved identification of desired (or undesired) cell types. The mRNA recovered from immunostained tissue is of high quality. Single-step PCR is able to amplify fragments of more than 600 bp from both housekeeping genes such as beta-actin as well as cell-specific messages such as CD4 or CD19, using cDNA derived from less than 500 immunostained, microdissected cells. Immuno-LCM allows specific mRNA analysis of cell populations isolated according to their immunophenotype or expression of function-related antigens and significantly expands our ability to investigate gene expression in heterogeneous tissues.


American Journal of Pathology | 2002

Evaluation of Non-Formalin Tissue Fixation for Molecular Profiling Studies

John W. Gillespie; Carolyn J.M. Best; Verena E. Bichsel; Kristina A. Cole; Susan F. Greenhut; Stephen M. Hewitt; Mamoun Ahram; Yvonne Gathright; Maria J. Merino; Robert L. Strausberg; Jonathan I. Epstein; Stanley R. Hamilton; Gallya Gannot; Galina V. Baibakova; Valerie S. Calvert; Michael J. Flaig; Rodrigo F. Chuaqui; Judi Herring; John Pfeifer; Emmanuel F. Petricoin; W. Marston Linehan; Paul H. Duray; G. Steven Bova; Michael R. Emmert-Buck

Using a general strategy for evaluating clinical tissue specimens, we found that 70% ethanol fixation and paraffin embedding is a useful method for molecular profiling studies. Human prostate and kidney were used as test tissues. The protein content of the samples was analyzed by one-dimensional gel electrophoresis, immunoblot, two-dimensional gel electrophoresis, and layered expression scanning. In each case, the fixed and embedded tissues produced results similar to that obtained from snap-frozen specimens, although the protein quantity was somewhat decreased. Recovery of mRNA was reduced in both quantity and quality in the ethanol-fixed samples, but was superior to that obtained from formalin-fixed samples and sufficient to perform reverse transcription polymerase chain reactions. Recovery of DNA from ethanol-fixed specimens was superior to formalin-fixed samples as determined by one-dimensional gel electrophoresis and polymerase chain reaction. In conclusion, specimens fixed in 70% ethanol and embedded in paraffin produce good histology and permit recovery of DNA, mRNA, and proteins sufficient for several downstream molecular analyses. Complete protocols and additional discussion of relevant issues are available on an accompanying website (http://cgap-mf.nih.gov/).


Clinical Cancer Research | 2005

Molecular Alterations in Primary Prostate Cancer after Androgen Ablation Therapy

Carolyn J.M. Best; John W. Gillespie; Yajun Yi; Gadisetti V.R. Chandramouli; Mark A. Perlmutter; Yvonne Gathright; Heidi S. Erickson; Lauren Georgevich; Michael A. Tangrea; Paul H. Duray; Sergio González; Alfredo Velasco; W. Marston Linehan; Robert J. Matusik; Douglas K. Price; William D. Figg; Michael R. Emmert-Buck; Rodrigo F. Chuaqui

Purpose: After an initial response to androgen ablation, most prostate tumors recur, ultimately progressing to highly aggressive androgen-independent cancer. The molecular mechanisms underlying progression are not well known in part due to the rarity of androgen-independent samples from primary and metastatic sites. Experimental Design: We compared the gene expression profiles of 10 androgen-independent primary prostate tumor biopsies with 10 primary, untreated androgen-dependent tumors. Samples were laser capture microdissected, the RNA was amplified, and gene expression was assessed using Affymetrix Human Genome U133A GeneChip. Differential expression was examined with principal component analysis, hierarchical clustering, and Students t testing. Analysis of gene ontology was done with Expression Analysis Systematic Explorer and gene expression data were integrated with genomic alterations with Differential Gene Locus Mapping. Results: Unsupervised principal component analysis showed that the androgen-dependent and androgen-independent tumors segregated from one another. After filtering the data, 239 differentially expressed genes were identified. Two main gene ontologies were found discordant between androgen-independent and androgen-dependent tumors: macromolecule biosynthesis was down-regulated and cell adhesion was up-regulated in androgen-independent tumors. Other differentially expressed genes were related to interleukin-6 signaling as well as angiogenesis, cell adhesion, apoptosis, oxidative stress, and hormone response. The Differential Gene Locus Mapping analysis identified nine regions of potential chromosomal deletion in the androgen-independent tumors, including 1p36, 3p21, 6p21, 8p21, 11p15, 11q12, 12q23, 16q12, and 16q21. Conclusions: Taken together, these data identify several unique characteristics of androgen-independent prostate cancer that may hold potential for the development of targeted therapeutic intervention.


Molecular Carcinogenesis | 2002

Proteomic analysis of human prostate cancer

Mamoun Ahram; Carolyn J.M. Best; Michael J. Flaig; John W. Gillespie; Isabel M. Leiva; Rodrigo F. Chuaqui; Ge Zhou; Hungjun Shu; Paul H. Duray; W. Marston Linehan; Mark Raffeld; David K. Ornstein; Yingming Zhao; Emanuel F. Petricoin; Michael R. Emmert-Buck

Proteomics is a promising approach in the identification of proteins and biochemical pathways involved in tumorigenesis. In an effort to discover such proteins and pathways that are deregulated in prostate tumorigenesis, cellular proteomes of matched normal prostate epithelial cells and high‐grade prostate cancer cells were analyzed by tissue microdissection, two‐dimensional electrophoresis, and mass spectrometry. Forty protein alterations were detected in the tumors; however, the majority of these changes were not shared among the 12 neoplasms. In contrast, parallel cDNA microarray analysis identified a number of common gene expression changes. The marked heterogeneity of the observed protein alterations may have significance with regard to tumor biology and research strategies for molecular profiling analyses of human prostate cancer. Published 2002 Wiley‐Liss, Inc.


American Journal of Pathology | 2000

Molecular profiling of clinical tissue specimens: feasibility and applications.

Michael R. Emmert-Buck; Robert L. Strausberg; David B. Krizman; M. Fatima Bonaldo; Robert F. Bonner; David G. Bostwick; Monica R. Brown; Kenneth H. Buetow; Rodrigo F. Chuaqui; Kristina A. Cole; Paul H. Duray; Chad R. Englert; John W. Gillespie; Susan F. Greenhut; Lynette H. Grouse; LaDeana W. Hillier; Kenneth S. Katz; Richard D. Klausner; Vladimir Kuznetzov; Alex E. Lash; Greg Lennon; W. Marston Linehan; Lance A. Liotta; Marco A. Marra; Peter J. Munson; David K. Ornstein; Vinay V. Prabhu; Christa Prange; Gregory D. Schuler; Marcelo B. Soares

The relationship between gene expression profiles and cellular behavior in humans is largely unknown. Expression patterns of individual cell types have yet to be precisely measured, and, at present, we know or can predict the function of a relatively small percentage of genes. However, biomedical research is in the midst of an informational and technological revolution with the potential to increase dramatically our understanding of how expression modulates cellular phenotype and response to the environment. The entire sequence of the human genome will be known by the year 2003 or earlier. 1,2 In concert, the pace of efforts to complete identification and full-length cDNA sequencing of all genes has accelerated, and these goals will be attained within the next few years. 3-7 Accompanying the expanding base of genetic information are several new technologies capable of global gene expression measurements. 8-16 Taken together, the expanding genetic database and developing expression technologies are leading to an exciting new paradigm in biomedical research known as molecular profiling.


Nature Protocols | 2009

Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples

Heidi S. Erickson; Paul S. Albert; John W. Gillespie; Jaime Rodriguez-Canales; W. Marston Linehan; Peter A. Pinto; Rodrigo F. Chuaqui; Michael R. Emmert-Buck

Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) is a valuable tool for measuring gene expression in biological samples. However, unique challenges are encountered when studies are performed on cells microdissected from tissues derived from animal models or the clinic, including specimen-related issues, variability of RNA template quality and quantity, and normalization. qRT-PCR using small amounts of mRNA derived from dissected cell populations requires adaptation of standard methods to allow meaningful comparisons across sample sets. The protocol described here presents the rationale, technical steps, normalization strategy and data analysis necessary to generate reliable gene expression measurements of transcripts from dissected samples. The entire protocol from tissue microdissection through qRT-PCR analysis requires ∼16 h.


The Journal of Urology | 1999

Long term organ culture of human prostate tissue in a NASA-designed rotating wall bioreactor

Leonid Margolis; Steven Hatfill; Rodrigo F. Chuaqui; Cathy D. Vocke; Michael R. Emmert-Buck; W. Marston Linehan; Paul H. Duray

PURPOSE To maintain ex vivo integral prostatic tissue including intact stromal and ductal elements using the NASA-designed Rotating Wall Vessel (RWV) which maintains colocalized cells in an environment that promotes both three-dimensional cellular interactions together with the uniform mass transfer of nutrients and metabolic wastes. MATERIALS AND METHODS Samples of normal prostate were obtained as a byproduct of transurethral prostatectomy or needle biopsy. Prostatic tissue dissected into small 1 x 1 mm. blocks was cultured in the Rotating Wall Vessel (RWV) Bioreactor for various time periods and analyzed using histological, immunochemical, and total cell RNA assays. RESULTS We report the long term maintenance of benign explanted human prostate tissue grown in simple culture medium, under the simulated microgravity conditions afforded by the RWV bioreactor. Mesenchymal stromal elements including blood vessels and architecturally preserved tubuloglandular acini were maintained for a minimum of 28 days. Cytokeratins, vimentin and TGF-beta2 receptor and ligand were preserved through the entire culture period as revealed by immunocytochemistry. Prostatic acid phosphatase (PAP) was continuously expressed during the culture period, although somewhat decreased. Prostatic specific antigen (PSA) and its transcript were down regulated over time of culture. Prostatic carcinoma cells from the TSU cell line were able to invade RWV-cultured benign prostate tissue explants. CONCLUSIONS The RWV bioreactor represents an additional new technology for culturing prostate tissue for further investigations concerning the basic physiology and pathobiology of this clinically important tissue.

Collaboration


Dive into the Rodrigo F. Chuaqui's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

John W. Gillespie

Science Applications International Corporation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

W. Marston Linehan

Science Applications International Corporation

View shared research outputs
Top Co-Authors

Avatar

Michael A. Tangrea

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Heidi S. Erickson

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Jaime Rodriguez-Canales

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kristina A. Cole

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Paul H. Duray

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge